Twist Bioscience Corporation (TWST) |
| 56.995 -0.415 (-0.72%) 04-15 13:36 |
| Open: | 57.41 |
| High: | 59.9 |
| Low: | 56.28 |
| Volume: | 564,797 |
| Market Cap: | 3,494(M) |
| PE Ratio: | -44.88 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 69.96 |
| Resistance 1: | 59.90 |
| Pivot price: | 49.64 |
| Support 1: | 48.54 |
| Support 2: | 41.52 |
| 52w High: | 59.9 |
| 52w Low: | 23.3 |
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
| EPS | -1.270 |
| Book Value | 7.440 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.297 |
| Profit Margin (%) | -19.56 |
| Operating Margin (%) | -31.73 |
| Return on Assets (ttm) | -13.5 |
| Return on Equity (ttm) | -16.8 |
Tue, 14 Apr 2026
Insider share sales disclosed — Company (NASDAQ: TWST) lists recent dispositions - Stock Titan
Tue, 14 Apr 2026
TWST Stock Climbs As Wall Street Hikes Price Targets - StocksToTrade
Mon, 13 Apr 2026
A Look At Twist Bioscience (TWST) Valuation After Strong Results Guidance Raise And Analyst Optimism - simplywall.st
Mon, 13 Apr 2026
Twist Bioscience CFO Laponis sells $129561 in shares - Investing.com
Mon, 13 Apr 2026
Twist Bioscience (TWST) CFO sells 2,597 shares to cover RSU taxes - Stock Titan
Sun, 12 Apr 2026
Behavioral Patterns of TWST and Institutional Flows - Stock Traders Daily
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |